Csl Behring
Clinical trials sponsored by Csl Behring, explained in plain language.
-
New Long-Lasting treatment tested for hemophilia b in china
Disease control OngoingThis study is testing a long-acting clotting factor medicine (rIX-FP) for Chinese males with hemophilia B. The goal is to see how well it prevents bleeding episodes when used regularly, and how it works to treat bleeds that happen anyway. Researchers will measure how long the med…
Phase: PHASE3 • Sponsor: CSL Behring • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC
-
New treatment aims to stop dangerous transplant complication
Prevention OngoingThis study is testing whether a protein called Alpha-1 Antitrypsin can prevent graft-versus-host disease (GVHD) in patients receiving stem cell transplants for blood cancers. GVHD is a serious complication where the donor's immune cells attack the patient's body. The trial involv…
Phase: PHASE2, PHASE3 • Sponsor: CSL Behring • Aim: Prevention
Last updated Mar 17, 2026 12:55 UTC